Professor of Pediatrics, Drexel University College of Medicine
Allergy & Immunology
Dr. David P. Skoner, MD
|
|
Give Review
David Skoner practices Allergy & Immunology. He researched medicine at Temple University School of Medicine. He received awards:"America's Top Doctors", "CMS Meaningful Use Stage 1 Certification" and "Pittsburgh Magazine". David Skoner is a published doctor as well. He has 100 publications published. The latest was: Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Intranasal triamcinolone and growth velocity.
- Impact of student pharmacist-delivered Asthma education on child and caregiver knowledge.
- Safety of sublingual immunotherapy Timothy grass tablet in subjects with Allergic rhinitis with or without conjunctivitis and history of asthma.
- Sublingual immunotherapy in children: the recent experiences.
- Effect of cetirizine on symptom severity and quality of life in perennial Allergic rhinitis.
- Ocular and nasal Allergy symptom burden in America: The Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys.
- The Allergies, Immunotherapy, and RhinoConjunctivitis (AIRS) survey: Patients' experience with allergen immunotherapy.
- Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoConjunctivitis (AIRS) surveys.
- Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial.
- An Asthma sports camp series to identify children with possible Asthma and cardiovascular risk factors.
- Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent Asthma.
- A critical review of the Effects of inhaled corticosteroids on growth.
- Effects of Inhaled Mometasone Furoate on Growth Velocity and Adrenal Function: A Placebo-Controlled Trial in Children 4-9 Years Old with Mild Persistent Asthma.
- Sublingual immunotherapy in patients with Allergic rhinoconjunctivitis.
- Efficacy and safety of timothy grass Allergy immunotherapy tablets in North American children and adolescents.
- Oseltamivir treatment for acute otitis media in children with influenza.
- Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild Asthma.
- Allergic rhinitis, histamine, and otitis media.
- Effect on growth of long-term treatment with intranasal triamcinolone acetonide aqueous in children with Allergic rhinitis.
- A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochlor...
- Addressing steroid phobia: improving the risk-benefit ratio with new agents.
- Antihistamines in the pediatric population: achieving optimal outcomes when treating seasonal Allergic rhinitis and chronic urticaria.
- Viral and bacterial Rhinitis.
- Role of single nucleotide polymorphisms of cytokine genes in spontaneous preterm delivery.
- Allergy skin test responses during experimental infection with respiratory syncytial virus.
- Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with Asthma.
- Nasal cytokines as mediators of illness during the common cold.
- Childhood socioeconomic status and host resistance to infectious illness in adulthood.
- Diminished dendritic cell interleukin 10 production in Atopic children.
- Association between TNF-alpha and TGF-beta genotypes in infants and parental history of Allergic rhinitis and asthma.
- Sociability and susceptibility to the common cold.
- Elevations of local leukotriene C4 levels during viral upper respiratory tract infections.
- Emotional style and susceptibility to the common cold.
- Comparison of subject-reported Allergy versus skin test results in a common cold trial.
- Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection.
- Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults.
- New enzyme immunoassay for salivary cortisol.
- The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with Allergic rhinitis.
- Effect of respiratory syncytial virus infection during early infancy on the ontogeny of cytokine immune responses.
- Viral infection and Allergy: lower airway.
- Use of intranasal cromolyn sodium for Allergic rhinitis.
- Nasal and otologic Effects of experimental respiratory syncytial virus infection in adults.
- Balancing safety and efficacy in pediatric Asthma management.
- Outcome measures in childhood Asthma.
- Growth effects of Asthma and Asthma therapy.
- Preliminary evidence for the feasibility of a stress management intervention for 7- to 12-year-olds with Asthma.
- Sublingual immunotherapy in patients with Allergic rhinoconjunctivitis caused by ragweed pollen.
- Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
- Effect of tetanus immunization on t-helper cytokine production in adults with and without Allergic rhinitis.
- Benefit and risk management for steroid treatment in upper airway Diseases.
- Association between environmental tobacco smoke and diminished dendritic cell interleukin 10 production during infancy.
- Cytokine levels during symptomatic viral upper respiratory tract infection.
- Comparison of objective and subjective measurements of cough frequency in patients with seasonal Allergic rhinitis.
- Update of growth Effects of inhaled and intranasal corticosteroids.
- The wheezing infant.
- Asthma and selective immunoglobulin subclass deficiency: improvement of Asthma after immunoglobulin replacement therapy.
- Montelukast in 2- to 5-year-old children with Asthma.
- Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchoPulmonary dysplasia in premature infants.
- A primate model for the evaluation of antihistamines.
- Otologic manifestations of experimental rhinovirus infection.
- Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus.
- Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.
- Prechallenge antibodies moderate Disease expression in adults experimentally exposed to rhinovirus strain hanks.
- Types of stressors that increase susceptibility to the common cold in healthy adults.
- Rhinovirus infection induces mucus hypersecretion.
- Effect of rimantadine treatment on clinical manifestations and otologic complications in adults experimentally infected with influenza A (H1N1) virus.
- Efficacy and safety of oral immunotherapy with short ragweed extract.
- Social ties and susceptibility to the common cold.
- Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
- Lower airway responses to rhinovirus-Hanks in healthy subjects with and without Allergy.
- Suppression of in vivo cell-mediated immunity during experimental influenza A virus infection of adults.
- Inhibition of the sodium, potassium adenosine triphosphatase enzyme in peripheral blood mononuclear cells of subjects with Allergic rhinitis.
- The relationship between airway hyperreactivity (AHR) and sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme inhibition.
- A role for the sodium, potassium adenosine triphosphatase (Na+,K+ ATPase) enzyme in degranulation of rat basophilic leukaemia cells.
- Risk/benefit ratio of inhaled steroids.
- Modulation of histamine release by sodium, potassium adenosine triphosphatase inhibition.
- Prechallenge antibodies: moderators of infection rate, signs, and symptoms in adults experimentally challenged with rhinovirus type 39.
- Lower airway responses to rhinovirus 39 in healthy Allergic and nonAllergic subjects.
- Lower airway responses to influenza A virus in healthy Allergic and nonAllergic subjects.
- Pattern of nasal secretions during experimental influenza virus infection.
- Effect of influenza A virus infection on natural and adaptive cellular immunity.
- Extended-release albuterol in the treatment of 6- to 12-year-old Asthmatic children.
- In vitro modulation of platelet sodium, potassium adenosine triphosphatase enzyme activity by antiAllergy drugs.
- Nasal and otologic Effects of experimental influenza A virus infection.
- Effect of rhinovirus 39 infection on cellular immune parameters in Allergic and nonAllergic subjects.
- Analysis of nasal secretions during experimental rhinovirus upper respiratory infections.
- Effect of experimental rhinovirus 39 infection on the nasal response to histamine and cold air challenges in Allergic and nonAllergic subjects.
- Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of Allergic and nonallergi...
- State and trait negative affect as predictors of objective and subjective symptoms of respiratory viral infections.
- Reproducibility of the effects of intranasal ragweed challenges in Allergic subjects.
- Evolving role of theophylline for treatment of chronic childhood Asthma.
- Influenza A virus--induced acute otitis media.
- Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in Allergic and non-Allergic subjects.
- Eustachian tube obstruction (ETO) after histamine nasal provocation--a double-blind dose-response study.
- Pediatric predictive index for hospitalization in acute Asthma.
- Eustachian tube obstruction after intranasal challenge with house dust mite.
- Increases in plasma concentrations of a prostaglandin metabolite in acute airway obstruction.
- Nasal physiology and inflammatory mediators during natural pollen exposure.
- Plasma elevations of histamine and a prostaglandin metabolite in acute bronchiolitis.
Schools
Temple Univ Sch Of Med
Chldns Hospital Med Center
Chldns Hospital
Procedures Preformed
- Allergy Shots
- Allergy Skin Testing
Conditions Treated
- Allergic Rhinitis
- Allergic Rhinitis Due to Food
- Anaphylaxis
- Angioedema
- View All
Doctors Specialties
- Pediatrics
- Allergy
- Immunology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Pittsburgh Magazine
Education
-
University of Pittsburgh Medical Center -
Cincinnati Children's Hospital Medical Center -
Temple University School of Medicine
Drug Facts
| NPI NUMBER | 1972504165 | |
| NPPES Provider LastName | SKONER | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 152124756 | |
| NPPES Provider State | PA | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 302.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972504165 |
| Last Name Of The Provider | SKONER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Marc D. Ikeda, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catalina Cleves Bayon, MD |
|
|
Dr. Julio E. Pena, MD |
|
|
Dr. Russell S. Traister, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merritt Fajt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sergei N. Belenky, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald A. Landay, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia A. Smetanka, MD |
|
|
Dr. William F. Coppula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen M. Murphey, MD
This Doctor is OpenDoctor Recommended.
|